Robotic Catheterization Systems Market is set to experience a significant growth of 14.8% CAGR from 2022 to 2029

A recent clinical study radiation level research with robotic catheterization and normal cardiac intervention procedures reveals that robotic catheterization systems show reduction of ionizing radiation exposure by 95%.

This factor will be prominent in pushing the preference for robotic catheterization systems as an effective procedure for catheterization. Projected to reach US$ 42.9 Mn by the end of 2022, robotic catheterization systems market is set to thrive at an impressive CAGR of 14.8% during the forecast period (2022 – 2029).

Interventional and surgical robotic systems have already made a significant impact on how surgeries are performed and are being increasingly adopted in modern operating rooms. Robotic catheterization systems have proved their abilities to perform interventional procedures with immensely low operator radiation exposure in comparison to the tradition catheterization procedures.

Ask for the Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9667

Procedures where clinicians are given navigational and mechanical tools that permit definite actions or part of the procedure to be executed autonomously with a level of precession and control are possible only with robot-assisted catheterization.

Key Takeaways – Robotic Catheterization Systems Market Study

  • Popularity of robotic catheterization systems, increasing system awareness, improving reimbursement scenarios for percutaneous coronary intervention (PCI), larger patient pool for coronary artery diseases are key factors influencing the robotic catheterization systems market in developed countries.
  • High upfront cost is posing a negative impact on end users’ decision to purchase robotic catheterized systems. To rework this problem, Hansen Medical is offering sensei system at a competitive pricing depicting lower accessory cost and lower total cost per procedure.
  • Robotic catheterization systems installed in Chesapeake Regional Healthcare marks as the first fully integrated catheterization laboratory installed in its all intervention operating room.
  • In terms of product type, electromechanical robotic catheterization systems with comparatively higher technical advantage over magnetic-guided robotic catheterization systems is expected to generate significant revenue.
  • In terms of application, increasing adoption of robotic catheterization for percutaneous coronary intervention as compared to cardiac electrophysiology procedure marks higher revenue potential.

The first ever successful robotic PCI procedure in Asia Pacific that delivered positive results will be offering an inception point for the growth of robotic catheterization systems market in developing Asian economies.

Market Leaders on Acquisition Spree

In reference to the trend in other medical device markets, key factors impacting the robotic catheterization systems market are partnerships and mergers observed in recent years. Key manufacturers are entering the robotic catheterization systems market by strategically expanding their reach through acquisitions and mergers, considering the increasing demand for these systems.

Product bundling of robotic catheterization and accessory systems at promotional rates and research contracts are forcing a decline in ASPs. Companies are focusing on limiting operational expenses to grow profitability. In contrast to these market changes, another significant factor influencing the robotic catheterization systems market is the exit and entrance of co-participating companies.

In August 2022, Corindus Vascular Robotics Inc., a prominent developer of precision vascular robotics, declared that it has settled on acquisition by Siemens Healthineers AG., representing a collective purchase price of approximately $1.1 billion.

In April 2016, Hansen Medical Inc. was acquired by Auris Surgical Robotics Inc. in an arrangement with roughly US$ 80 Mn of equity value. With Hansen portfolio, Auris attained Magellan Robotic System, employed in navigating peripheral blood vessels in endovascular procedures, and Sensei Robotic System, a robotically steerable catheter system.

Looking for More Insights?

Robotic catheterization systems market, a new study from Future Market Insights, provides unparalleled insights on evolution of the robotic catheterization systems market during 2014 – 2021 and presents demand projections during 2022 – 2029 on the basis of product category (Electromechanical robotic catheterization systems, magnetic-guided robotic catheterization systems), application (percutaneous coronary intervention, cardiac electrophysiology procedures), and end user (hospitals, ambulatory surgical centers, catheterization laboratories) across seven prominent regions.

Ask for the Complete TOC of this Report: https://www.futuremarketinsights.com/reports/robotic-catheterization-systems-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Osmotic Pumps Market: Increasing Demand for Efficient Management Practices Report 2022-2029

There are different modalities of drug delivery system present for each condition. Oral drug delivery system is one of the most widely used delivery system for pharmaceuticals. Oral route for its many advantages s considered to be the preferred choice within the consumer side. Osmotic pumps are primarily used for controlled release formulations as they tend to work efficiently well with the type of drugs. Osmotic pumps runs on the principle of osmosis that can be defined as the natural flow of a solvent from a solution of low solute concentration to a solution of higher solute concentration through a semipermeable membrane.

Osmotic Pumps Market: Drivers and Restraints

The scenario for drug delivery systems has changed over the years. Major healthcare and governing bodies offer prime support to patients with chronic diseases, increasing the use and presence of osmotic pumps to a greater extent.

Request for the Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9664

Osmotic pumps are extremely useful for patients with chronic illness, where there is a requirement of drug to be within the therapeutic range of action. With the use of osmotic pumps drug delivery can be delayed or pulsed accordingly. Such clinical differences and advantages push the market to a better state than today. There are reimbursement plans present for osmotic pumps that changes the market structure by increasing the adoption rate of each device. Consumer pulling strategies are implemented by manufacturers to increase the awareness regarding osmotic pumps. Extensive and target approach by manufacturers could increase revenue potential for each offering. The market expansion is also in relation with the ageing population who are dependent on better drug delivery systems that can be provided with the use osmotic pumps. The osmotic pumps industry is exercising a great run over the period with new emerging players cutting the cost for each device, it indirectly increases the adoption rate for osmotic pumps.

Osmotic Pumps Market: Overview

The global market for osmotic pumps is expanding with the emergence of new manufacturers and better technological advances. There are better osmotic pumps available in the market influencing the current structure, the adoption of newly launched products is significant. Osmotic pumps like L-OROS pump, controlled porosity osmotic pump and sandwiched osmotic tablet are few of the recently launched products having a considerable high growth rate. The year on year sales of these products is significant, this makes this osmotic pumps market extensively lucrative for emerging companies. By product type the osmotic pumps market is segment into two primary units; oral osmotic pump and implantable osmotic pump. Oral osmotic pump is widely used and has a greater number of variants in the industry, the growth rate for implantable osmotic pump is more as compare to the other. Osmotic pumps are the most reliable controlled drug delivery system available with present clinical backing.

Osmotic Pumps Market: Regional Wise Outlook

Geographically, the osmotic pumps market is segmented into seven regions viz. Europe, North America, Latin America, Oceania, South Asia, East Asia and Middle East and Africa. The Europe osmotic pumps market is a lucrative market opportunity for manufacturers, with present infrastructure promoting better drug delivery systems in Europe makes it rather profitable business space.

Economical, physical and government factors influence the South Asia osmotic pumps market. North America region has its own significant share in the osmotic pumps market and the region is expected to expand with most of the manufacturer’s direct presence in the region.

Few of the players involved in this market for osmotic pumps include DURECT Corporation. The present market structure of osmotic pumps include very few companies with top tier companies having a considerable market share.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Osmotic Pumps market report includes

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Osmotic Pumps Market: Segmentation

Tentatively, the global osmotic pumps market has been segmented on the basis of product type, end user and geography.

Based on product type, the global osmotic pumps market is segmented as

  • Oral Osmotic Pump
  • Implantable Osmotic Pump

Based on end user, the global osmotic pumps market is segmented as:

  • Hospital
  • Ambulatory Surgical Centers
  • Specialty Clinic
  • Homecare Setting

Request for the complete TOC of this Report: https://www.futuremarketinsights.com/toc/rep-gb-9664

Osmotic Pumps Market Report Highlights: 

  • Overview of Global Healthcare Market
  • Evolution of the technology
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Laser Therapy Devices Market Overview by Device Type: Solid-State Laser, Gas Laser, Liquid Laser, Semiconductor Laser – Forecast to 2022-2031

Future Market Insights’ (FMI) latest report on the global laser therapy devices market expects a healthy growth trend, reach a value of almost US$ 2 billion by 2022, registering a CAGR of around 4%. Long-term prospects also appear bright, with numerous large-scale investments underway to adopt laser treatment procedures, amid rising inclination towards minimally invasive surgeries.

As per FMI’s analysis, oncology and aesthetics treatment are expected to emerge as key growth engines, followed by ophthalmology applications. Furthermore, preference for low level laser therapy (LLLT) is expected to increase, prompting key manufacturers to introduce a slew of innovative laser therapy devices solutions in the long-run. In 2019, the US Food & Drug Administration approved the Erchonia FX 635, a LLLT device to address whole-body pain, reducing the incidence by nearly 50%.

Get the Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5241

According to the Cancer Atlas, there were an estimated 18.1 million active cases, with over 9 million cancer deaths in 2018. Additionally, nearly 44 million individuals persons living with cancer that same year who were diagnosed within the previous’ five years. It is projected that this burden is expected to rise by over 60% by 2040. Hence, credible progress is expected to be made in this regard.

Key Takeaways from FMI’s Laser Therapy Devices Market Study

  • By device type, gas laser therapy devices to account for more than a quarter of the revenue share through 2021
  • A fifth of the total laser therapy devices revenue is accounted for by hospitals, specialty clinics to generate over half of the total share
  • Ophthalmology treatment is likely to account for the bulk of the revenue share in the laser therapy devices market
  • US and UK to experience high sales amid surging popularity of low-level laser therapy (LLLT)
  • High prevalence rates of dermatological disorders to fuel laser therapy device sales across Germany
  • Robust healthcare research funding and a flourishing aesthetics industry to pivot French laser therapy devices market growth
  • High plastic surgery rates to heighten China’s share in the laser therapy devices market

“Prominent laser therapy devices manufacturers are introducing portable handheld devices in order to enhance the comfort factor for surgeons while administering the appropriate treatment, improving patient outcomes and success rates,” says the FMI analyst.

Competitive Landscape

Boston Scientific Corporation, IPG Photonics Corporation, Lumenis Ltd., Coherent Inc., Biolitec AG, Hologic Inc., Alma Lasers Ltd., Fotona D.D, Danaher Corporation and Thermo Fisher Scientific Inc. are some prominent laser therapy devices manufacturers as profiled by FMI’s report. New product launches, capacity expansion initiatives and securing regulatory approvals for specific techniques are some key growth strategies.

In 2018, Hologic Inc. received a medical device license issued by Health Canada to market Cynosure’s advanced non-invasive body contouring product called SculpSure®, a laser treatment device for treating back, inner and outer thighs, and submental area under the chin. This approach destroys fat cells by raising body fat temperature.

Recently, in April 2021, Alma Lasers Ltd. launched the Alma PrimeXTM platform, a non-invasive approach for body contouring and skin tightening in the abdomen, waist, thighs and buttock areas. It deploys a combination of ultrasound and radiofrequency technologies.

More Insights on the Global Laser Therapy Devices Market

In its latest report, FMI offers an unbiased analysis of the global laser therapy devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of device type (solid-state laser, gas laser, liquid laser and semiconductor laser), end-user (hospitals, ambulatory surgical centers, specialized clinics and other end-users), application (ophthalmology, dermatology, gynecology, dentistry, urology, cardiovascular and others) and region (North America, Latin America, Europe, Japan, APEJ and Middle East & Africa).

Get the complete TOC of this Report with figures: https://www.futuremarketinsights.com/reports/laser-therapy-devices-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Pharmacovigilance Market is Growing with the Top Key Companies: Accenture Plc., Bristol-Myers Squibb, Clinquest Group B.V. & Cognizant Technology Solutions, Forecast to- 2022-2031

ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials.

As per FMI’s analysis, the market is expected to register double-digit growth, experiencing an impressive CAGR throughout the forecast period. Historically, the market posted credible gains, surpassing US$ 6 billion in 2020, expanding at a CAGR of over 14%. Growth prospects were further heightened during the COVID-19 pandemic, as the scramble for new treatment approaches is prompting pharmaceutical companies to initiate clinical trials for the same.

Download the Report sample : https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Prominent pharmaceutical companies are forging long-term partnerships and service agreements with contract research organizations and business processing outsourcing units to enhance existing pharmacovigilance operations by virtue of cost reduction from drug delivery to post-marketing approvals. In April 2021, Thermo Fisher Scientific Inc. announced its plans to acquire Pharmaceutical Product Development (PPD) Inc. for a purchase price of US$ 17.4 billion, which will help enhance the latter’s pharmacovigilance portfolio expansion.

Key Takeaways from FMI’s Pharmacovigilance Market Study

  • By phase of drug development, stage IV clinical trials pharmacovigilance solutions account for over 3 out of 4 applications
  • Based on method type, targeted spontaneous reporting to make maximum use of pharmacovigilance solutions
  • By service provider type, contract outsourcing to generate almost two out of five pharmacovigilance solutions uptake
  • US experiencing robust pharmacovigilance solutions providers presence amid prevalence of good PV practices
  • Forthcoming clinical trials for numerous drug candidates through 2021 to widen UK’s growth prospects
  • India to emerge as an emerging pharmacovigilance hub amid growing trends of medical operations outsourcing
  • China to experience growth on the back of recent amendments to render pharmacovigilance implementation stronger

“Rising prevalence of chronic and infectious ailments is prompting multiple pharmaceutical giants to initiate widespread clinical trials for potential drug molecules, generating a highly competitive environment and generating major revenue pools,” says the FMI analyst.

Competitive Landscape

Prominent pharmacovigilance solutions providers are relying on collaborating with prominent biopharmaceutical and pharmaceutical companies to offer their digital solutions to facilitate effective patient care solutions. Also, offering advanced solutions is another prominent strategy. Some prominent faces include F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among others.

Covance Inc. is a prominent pharmacovigilance solutions providing, offering end-to-end PV services spanning clinical and post-marketing phases from medical contract centers to ICSRs to medical reviews to electronic regulatory submissions. The system helps track weekly, daily and monthly metrics for quality, productivity and efficiency.

In April 2020, ICON Plc. initiated efforts to enhance pharmacovigilance practices, considering the onset of COVID-19. A webinar conducted on this issue by the company called for key pharmaceutical companies to automate their workflows by installing proactive and dedicated intelligence processes, forging detailed business and continuity plans and a virtually globally distributed footprint.

More Insights on the Global Pharmacovigilance Market

In its latest report, FMI offers an unbiased analysis of the global pharmacovigilance market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of phase of drug development (preclinical studies, phase I, phase II, phase III and phase IV), type of methods (spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring and EHR mining), service type provider (in-house pharmacovigilance and contract outsourcing) and region (North America, Latin America, Europe, Asia-Pacific and Middle East & Africa).

Download the TOC of this Report: https://www.futuremarketinsights.com/reports/pharmacovigilance-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Sports Medicine Market is Set to Exhibit Robust Growth Expanding at Over 7.5% CAGR Between the Time Period of 2021 and 2031

Demand for sports medicines is gaining traction as the sports industry is getting back on track after a temporary period of lull, following the COVID-19 outbreak. According to a study by Future Market Insights, the market will showcase recovery 2021 onwards, a trend which is expected to result in accelerating sales through 2031.

As the requirement for sports medicines for various types such as body reconstruction, body monitoring & evaluation, and others is rising again, the market is projected to record robust growth in the coming years. The latest revised edition of the report on ‘sports medicine’ market study by Future Market Insights (FMI) offers a thorough analysis of the global trends, demand-supply trajectories, and growth & restraining factors for sports medicine suppliers during the forecast period of 2021 to 2031.

Click to get the Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5173

According to the report, knee & shoulder injuries will account for the increasing sales of sports medicine while the focus of manufacturers will be on the leading regions such as North America, Europe, and Asia Pacific.

Key Takeaways from Market Study

  • The global sports medicine market is forecast to expand at over 7.5% CAGR through 2031
  • High demand for body reconstruction and body support & recovery type of sports medicine to fuel the sales
  • Rise in application in knee, shoulder, and ankle & foot injuries to cater to the growth of manufacturers
  • The United States to maintain its lead in the world’s largest sports medicine industry North America
  • Germany remains dominant in Europe sports medicine industry
  • Asia Pacific to emerge a highly lucrative market for sports medicine with its epicenters in China and India
  • Japan, the United Kingdom, Canada, France, Italy, and a few other countries to maintain positive market outlook

“Companies operating in the sports medicines market are focusing on innovations and product launches, besides aiming for certifications from international organizations. There is increasing focus on keeping pace with changing consumer preferences” says an FMI analyst.

Knee & Shoulder Injuries Fuelling Sports Medicines Sales

Rise in application of body reconstruction, body recovery, and other type of sports medicine in knee & shoulder injuries is becoming prominent around the globe. This in turn is set to raise the profit margins of suppliers in the near future.

According to the National Health Statistics Report published on 18th November, 2016, an average annual estimate of 8.6 million sports and recreation related injuries were reported among which knee & shoulder injuries were of the highest number. As stated in the report, one-half of the injury episodes resulted in treatment at a doctor’s office or health clinic while rest half needed emergency care or hospitalization. These figures represent why this segment is gaining momentum in terms of application.

Who is Winning?

The global sports medicine market is fragmented and thriving on the key players. In order to sail through the cut-throat competition, key players are launching diverse range of cost-effective products and services. For instance,

  • Breg Inc. launched its new brand for Orthopedic Service Lines which include OrthoSelect® Consulting, BregBill Programs, Breg Vision® Software, and others on 7th March, 2018
  • Medtronic Plc. launched its new range of Spinal and Orthopaedic Products and solutions such as T2 Stratosphere, Electrosurgical Products, and others a couple of years back

More Valuable Insights

In its latest report, FMI offers an unbiased analysis of the sports medicine market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (body reconstruction, body support & recovery, body monitoring & evaluation, and accessories), and application (knee injuries, shoulder injuries, ankle & foot injuries, back & spine injuries, elbow & wrist injuries, hip injuries, and other applications), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Click to get the TOC of this Report: https://www.futuremarketinsights.com/reports/sports-medicine-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Coated Fabrics Market to grow at nearly 5.1% CAGR during 2021-2031

The global coated fabrics market is set to be valued at US$ 19,976.7 Mn in 2021, with a stable long-term projection, according to latest insights from Future Market Insights, an ESOMAR-certified research and consulting firm. The report forecasts the global coated fabrics market to grow at nearly 5.1% CAGR during 2021-2031. The report offers analysis in 20+ high-growth markets, providing detailed insights on Coated Fabrics growth will evolve in the next decade.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-288

Demand for coated fabrics waned in 2020, and due to the economic impact of the unprecedented COVID-19 crisis. However, the manufacturing industry is currently in recovery mode. Considering the possibility of a stimulus in many countries, the long-term outlook on the market remains positive. Rising application in the transportation segment will continue supporting growth. According to FMI, above 34% of sales in terms of application will concentrate in this sector.

Key Takeaways

  • China, Japan, South Korea and ASEAN countries are witnessing high demand for coated fabric
  • China being the largest market in the world, is also expected to hold highest share in the coated fabrics due to presence of strong local base and extensive production facilities and availability of raw materials
  • The U.S. emerges as a leading market, accounting for over 84% sales in North America.
  • Increasing automotive sales will support growth in the U.K., enabling it to exhibit 5.6% y-o-y growth in 2021
  • Germany and France too will record high growth, driven by increasing focus on workplace safety

The COVID-19 pandemic is currently impacting the global economy at various levels and the impact is seen on coated fabrics market as well.  The market growth is projected to be affected by the COVID-19 pandemic crisis and it is expected to witness a significant drop in demand in 2021. With a number of end-use industries affected in several countries, the growth has also been impacted due to challenges in manufacturing sector. The shortage in demand are expected to result in a significant drop in Y-O-Y growth yet FMI expects Coated Fabrics to grow at 5.1% CAGR through 2031.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-288

Competitive Landscape

The market is moderately consolidated, with key players accounting for significant market share. Some of the key players in the market are Saint Gobain S.A, Bayer AG, PPG Industries, 3M Company, among others. These players are likely to invest in new technologies, especially customized variants, to maintain their market share.

Coated fabrics market is likely to grow at a moderate pace during 2021-2031. However, as it is a matured market, companies are expected to concentrate further on research and development activities to develop specific purpose that meet personalized requirements of end users. Collaboration with regional manufacturers is framed as a prime strategy expected magnify in the forecast.

Coated Fabrics Market Key Segment

By Application

  • Commercial Tents
  • Furniture
  • Industrial
  • Protective Clothing
  • Transportation
  • Others

By Material

  • Polymer Coated
  • Rubber Coated
  • Others

By Region

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Middle East & Africa (MEA)
  • Japan
  • Asia Pacific (Excluding Japan)

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-288

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Biophotonics Market is expected to register a CAGR of over 11.3% between 2022 and 2031

Future Market Insights (FMI) released its latest report on biophotonics market. The market is expected to register a CAGR of over 11.3% between 2021 and 2031. The study takes into account the impact of COVID-19 on Biophotonics Market.

The global biophotonics market is driven by factors such as Increasing ageing population, the government support in technology innovations, enhanced range of biophotonics applications, and a need for improvement in healthcare.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-92

Region-wise, North America was the highest contributor to the global biophotonics market, followed by Europe, the Middle East and Africa (EMEA) and Asia Pacific. However, the North America is expected exhibit a CAGR of over 10.9% during the forecast period

According to end-user type, the global biophotonics market is segmented as Medical diagnostics, Medical therapeutics, Test components and Non- Medical. The medical diagnostics is expected to dominate the global biophotonics market and register a CAGR of over 10.7%during the forecast period.

Non-medical applications are projected to demonstrate an impressive growth rate of over 15.5% CAGR between 2021 and 2031. Growth in global biophotonics market is largely attributed to growth in end use sectors, which largely include diagnostic centers, medical institutes, healthcare service providers, research institutes and laboratories, and medical & scientific instrument manufacturers.

By application type, the Global Biophotonics market is segmented as See through imaging, Spectro molecular, Inside imaging, Biosensors, Surface imaging, Microscopy, Light therapy, and other analytic sensing. Among all the aforementioned segments, the biosensors is projected to witness over 17.2% CAGR during the forecast period. The microscopy and light therapy applications are expected to exhibit a CAGR of 15.1 % each respectively between 2021 and 2031.

The growth is attributed to implementation of the biosensors in other analytic sensing segment due to its specific biological analyte sensing capability such as pregnancy test, food toxicity, and cholesterol tests. Key players in the global biophotonics market are Becton, Dickinson & Co., Affymetrix Inc., Carl Zeiss, Olympus America, Andor Technology and Hamamatsu Photonics.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-92

In this study, we analyze the Global Biophotonics Market during 2021-2031. We focus on:

  • Market size and forecast
  • Key drivers and developments in biophotonics
  • Key Trends and Developments of biophotonic products in applications such as see through imaging, inside imaging, spectro molecular, light therapy and others
  • Key Drivers and developments in particular regions such as North America, Europe, Asia-Pacific Middle East and Africa (MEA) and Latin America
  • Government policies and initiatives for biophotonics market in all four regions

Biophotonics Market Segments

  • By Application
    • See-Through Imaging
    • Microscopy
    • Inside Imaging
    • Spectro Molecular
    • Analytics Sensing
    • Light Therapy
    • Surface Imaging
    • Biosensors
  • By Application
    • See-Through Imaging
    • Microscopy
    • Inside Imaging
    • Spectro Molecular
    • Analytics Sensing
    • Light Therapy
    • Surface Imaging
    • Biosensors
  • By End User
    • Tests And Components
    • Medical Therapeutics
    • Medical Diagnostics
    • Non-Medical Application
    • Tests And Components
    • Medical Therapeutics
    • Medical Diagnostics
    • Non-Medical Application
  • By Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-92

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

India Construction Chemicals Market is anticipated to reach a value of US$ 21.7 Bn by 2031 end

Primary application of construction chemicals is to improve strength, durability, and workability of construction chemicals. The robust expansion of the Indian real estate sector and increasing investments in commercial and residential construction projects will fuel the demand in the India construction chemicals market.

As per Future Market Insights’ analysis, the India construction chemicals market is anticipated to reach a value of US$ 21.7 Bn by 2031 end, expanding at a CAGR of 13.6% during 2021-2031.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-in-87

Commonly used construction chemicals in India includes admixtures, water proofing chemicals, adhesives and sealants, protective coatings, and asphalt additives. The demand for construction chemicals is largely driven by affordable housing residential projects, in addition to infrastructure projects initiated by the government. Foreign direct investments are also likely to boost the sales in the country over the coming years.

However, the ongoing crisis caused by COVID-19 virus, has resulted in a short-term slump of production and distribution chains in the industry. Raw materials required for the production of construction chemicals are manufactured by chemical companies, which experienced a downturn during the pandemic as the supply chains were disturbed due to strict lockdown restrictions.

Furthermore, the construction sector in India was highly impacted by the pandemic, as ongoing and upcoming construction projects have been delayed or cancelled.

Key Takeaways from India Construction Chemicals Market Study

  • India Construction Chemicals Market will continue expanding, reaching a valuation of US$ 21,642 Mn by 2031, primarily driven by infrastructure investments.
  • Water proofing and protective coatings collectively holds more than 50% of the market share in the country’s market, with impetus provided from renovation and repair applications.
  • Governmental spending in the construction chemical sector has risen by approximately 1.8 times owing to the “Make in India” scheme for infrastructure and industrial development.
  • North and South India account for 30% of the overall Indian construction chemicals market each, with major investments into smart city projects.
  • The COVID-19 outbreak has resulted the construction industry in India coming to a standstill. As such, the construction chemicals market experienced a CAGR of -12.6% in 2020.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-in-87

Want to Know More?

Future Market Insights has published a market research report on the India Construction Chemicals Market that contains global analysis for 2016–2020 and opportunity assessment for 2021–2031. The report provides insightful analysis of the India Construction Chemicals Market through five different segments- Gas type, by End Use Equipment, by application, By End Use and region.

Construction Chemicals Market Key Segments

By Product Type:

  • Concrete Admixtures
  • Waterproofing Chemicals
  • Protective Coatings
  • Adhesives & Sealants
  • Concrete Repair Mortar
  •  Plaster
  • Asphalt Additives

 By Application:

  • Infrastructure
  • Commercial & Industrial
  • Residential

By Region:

  • North
  • South
  • East
  • West

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-in-87

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com

Automated Suturing Devices Market Overview with Analysis of Key Players: Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery & EndoEvolution, LLC, Forecast to 2022-2031

Surging adoption of minimally invasive procedures due to the rising prevalence of cardiovascular disease and rising incidents leading to trauma and open surgeries is augmenting the growth of automated suturing devices market.

According to Future Market Insights, the global automated suturing devices is poised to expand at a CAGR of 7.3% to reach a valuation of approx. US$ 473 million through 2021 and beyond.

Increasing research & development for advanced automated suturing devices due to the rising adoption of minimally invasive procedure is anticipated to accelerate the demand across countries such as U.S., Japan, India, China and UK.

Ask for the Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-579

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market across Asia Pacific excluding Japan (APEJ).

Rising preference for automated suturing devices over conventional ones during laparoscopic surgery is a major factor for market growth. Furthermore, the device is also preferred by procurement teams at hospitals as it’s labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Thereby, improving the market growth.

Key Takeaways from FMI’s Automated Suturing Devices Market Study

  • By product type, disposable automated suturing devices to emerge as lucrative segment through 2021
  • Increasing application in minimally invasive surgeries to stimulate suturing devices sales
  • The U.S. is expected to experience noteworthy expansion amid robust presence of regional suture devices manufacturers, experiencing 1.9x growth
  • India and China are expected to offer lucrative opportunities across South Asia & East Asia
  • Japan is expected to register a stellar growth on the back of rising adoption of minimally invasive procedures
  • Growing cases of gastrointestinal diseases to widen automated suturing devices adoption across Germany

“Visibly increasing adoption of minimally invasive procedures is likely to amplify demand of automated suturing devices among prominent automotive manufacturing giants,” says the FMI analyst. 

Competitive Landscape

Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc. and SuturTek Inc. are some prominent players operating in the automated suturing devices market.

Product development and innovation of new devices coupled with strategic mergers and acquisition remains the core strategy for the leading players to maintain a strong foothold in the industry.

In December 2019, for instance, a global leading player, Advanced Medical Solutions Group PLC, manufacturer of tissue adhesives, sutures, hemostats, and internal fixation devices, announced the acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, another leading player, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for the use with the Over Stitch Endoscopic Suturing Systems.

Furthermore, in June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for Over Stitch Sx Endoscopic Suturing System. The endoscopic suturing systems allowed physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.

More Insights on the Global Automated Suturing Devices Market

In its latest report, FMI offers an unbiased analysis of the global automated suturing devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (disposable and reusable), application type (minimally invasive surgeries, open surgeries, and trauma) across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa)

Ask for the TOC of this Report: https://www.futuremarketinsights.com/reports/automated-suturing-devices-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Dilated Cardiomyopathy Market Covid-19 Impact Analysis, Opportunities, Threats, Drivers, Restraints, Trends, Applications, And Growth Forecast To 2027

Dilated Cardiomyopathy Market: Regional Overview

Dilated Cardiomyopathy Market is classified into seven regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America occupies the significant market share in dilated cardiomyopathy market. Due to high incidence rates of congestive heart failures in the region. Next to North America, Europe holds the second leading market share for dilated cardiomyopathy conditions. According to European Federation of Pharmaceutical Industries and Associations, over 6000,000 are admitted to hospital, and 55,000 deaths are caused due to the congestive heart failure conditions in Europe. However, APEJ market is expected to grow over the forecast due to increase in awareness and increasing demand for generic drugs are responsible for growth of the market over the forecast period.

Dilated cardiomyopathy is condition caused due to enlargement of left ventricle in the heart. In this state left ventricle gets enlarged, and the heart walls become thinner to pump blood from heart to other body parts of the body. Dilated cardiomyopathy can be developed at any age however it is more common in the people age between 20 to 60 years. In some cases, right ventricle also might be affected due to myopathy. Dilated cardiomyopathy is often caused by genetic mutations and non-genetic conditions like exposure to toxins, autoimmune diseases, heart valve abnormalities and diabetes disease conditions. However, there was no drug approved by FDA to treat dilated cardiomyopathy conditions. Companies are actively working on to develop molecules to treat dilated cardiomyopathy conditions. Array BioPharma carrying out Phase 2 clinical trial for ARRY-797 that inhibits p38 mitogen-activated kinase inhibitor to treat dilated cardiomyopathy. In December 2015, U.S. FDA gave Orphan drug status to the Vasomera (PB1046) molecule developed by PhaseBio Pharmaceuticals that is used treat X-linked dilated cardiomyopathy conditions. Vericel Corporation working on innovative concept to treat dilated cardiomyopathy conditions. Company has developed Ixmyelocel-T, multicellular therapy to treat dilated cardiomyopathy.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2830

Dilated Cardiomyopathy Market: Drivers and Restraints

Globally increase in incidences of congestive heart failure conditions which is leading cause of dilated cardiomyopathy conditions. According to American Heart Association, around 5.3 million Americans have congestive heart failure within an incidence of 660,000 cases diagnosed yearly this signifies potential of the market. The major restraints for the market lack of proper drugs, increase in usage of defibrillators and pacemakers are effecting growth of this market.

Dilated Cardiomyopathy Market: OverviewNormally to treat dilated cardiomyopathy conditions, physicians use the drugs that can treat for congestive heart failure conditions this is due to lack of drugs for dilated cardiomyopathy conditions. Angiotensin receptor blockers occupy the major market share followed by beta blockers by beta blockers. In case of distribution channel, retail pharmacies hold the major market share followed by hospital pharmacies due to easy availability of drugs.

Dilated Cardiomyopathy Market: Players

Some of the players in the dilated cardiomyopathy Pfizer Inc., Array BioPharma, Vericel Corporation,PhaseBio Pharmaceuticals, Pfizer Inc., GlaxoSmithKline plc, Johnson and Johnson, Merck & Co., Inc, Teva Pharmaceuticals, Astrazeneca plc and Sanofi

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2830

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Dilated Cardiomyopathy Market: Segmentation

The global Dilated Cardiomyopathy Market is classified on the basis of drug class, distribution channel and geography.

Based on drug class, the dilated cardiomyopathy market is segmented into the following:

  • Angiotensin-converting enzyme (ACE) inhibitors
  • Angiotensin II receptor blockers
  • Beta blockers
  • Diuretics
  • Blood thinning medications
  • Cardiac glycosides

Based on distribution channel, the dilated cardiomyopathy market is segmented into the following:

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Mail order Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/2830

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com